BNP Paribas Financial Markets’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$93M Sell
280,965
-108,470
-28% -$36.9M 0.06% 437
2025
Q4
$155M Buy
389,435
+236,396
+154% +$105M 0.1% 259
2025
Q3
$69.8M Buy
153,039
+24,405
+19% +$9.94M 0.05% 485
2025
Q2
$41.9M Buy
128,634
+86,059
+202% +$23.8M 0.03% 660
2025
Q1
$11.5M Buy
42,575
+857
+2% +$220K 0.01% 1334
2024
Q4
$9.82M Sell
41,718
-73,066
-64% -$19.2M 0.01% 1373
2024
Q3
$31.6M Sell
114,784
-11,228
-9% -$2.92M 0.03% 677
2024
Q2
$30.6M Buy
126,012
+24,566
+24% +$3.88M 0.03% 589
2024
Q1
$15.2M Buy
101,446
+18,742
+23% +$3.13M 0.02% 899
2023
Q4
$15.8M Buy
82,704
+31,301
+61% +$5.33M 0.03% 810
2023
Q3
$9.1M Buy
51,403
+12,822
+33% +$2.45M 0.02% 943
2023
Q2
$7.33M Sell
38,581
-32,502
-46% -$6.44M 0.01% 1040
2023
Q1
$14.2M Buy
71,083
+42,972
+153% +$9.03M 0.03% 739
2022
Q4
$6.68M Sell
28,111
-61,239
-69% -$13.1M 0.02% 1166
2022
Q3
$17.9M Buy
89,350
+32,229
+56% +$6.15M 0.05% 684
2022
Q2
$8.33M Sell
57,121
-9,579
-14% -$1.36M 0.02% 995
2022
Q1
$10.9M Buy
66,700
+681
+1% +$104K 0.02% 886
2021
Q4
$11.2M Sell
66,019
-11,162
-14% -$2.07M 0.03% 910
2021
Q3
$14.6M Buy
77,181
+57,144
+285% +$10.7M 0.03% 753
2021
Q2
$3.4M Sell
20,037
-3,958
-16% -$580K 0.01% 1502
2021
Q1
$3.39M Sell
23,995
-14,050
-37% -$2.11M 0.01% 1388
2020
Q4
$4.94M Buy
38,045
+1,184
+3% +$158K 0.02% 1140
2020
Q3
$5.37M Sell
36,861
-14,099
-28% -$2M 0.01% 1052
2020
Q2
$7.55M Sell
50,960
-4,209
-8% -$567K 0.02% 841
2020
Q1
$6.01M Sell
55,169
-27,553
-33% -$3.18M 0.02% 897
2019
Q4
$9.53M Buy
82,722
+36,448
+79% +$3.63M 0.04% 867
2019
Q3
$3.72M Sell
46,274
-1,681
-4% -$133K 0.01% 1209
2019
Q2
$3.48M Buy
47,955
+9,884
+26% +$758K 0.01% 1204
2019
Q1
$3.56M Sell
38,071
-3,898
-9% -$326K 0.01% 1131
2018
Q4
$3.06M Buy
41,969
+14,163
+51% +$1.09M 0.02% 1124
2018
Q3
$2.43M Buy
27,806
+9,562
+52% +$962K 0.01% 1415
2018
Q2
$1.8M Buy
18,244
+2,870
+19% +$285K ﹤0.01% 1522
2018
Q1
$1.83M Buy
15,374
+3,298
+27% +$425K 0.01% 1432
2017
Q4
$1.53M Buy
12,076
+2,579
+27% +$324K 0.01% 1663
2017
Q3
$1.12M Sell
9,497
-3,503
-27% -$299K ﹤0.01% 1492
2017
Q2
$1.04M Sell
13,000
-2,043
-14% -$131K ﹤0.01% 1514
2017
Q1
$771K Sell
15,043
-728
-5% -$33.6K ﹤0.01% 1494
2016
Q4
$590K Buy
15,771
+5,231
+50% +$219K ﹤0.01% 1608
2016
Q3
$714K Sell
10,540
-586
-5% -$41.3K ﹤0.01% 1046
2016
Q2
$617K Buy
11,126
+2,156
+24% +$136K ﹤0.01% 1403
2016
Q1
$563K Sell
8,970
-6,660
-43% -$443K ﹤0.01% 1169
2015
Q4
$1.47M Buy
15,630
+4,847
+45% +$449K ﹤0.01% 1009
2015
Q3
$867K Sell
10,783
-78,631
-88% -$8.74M ﹤0.01% 1093
2015
Q2
$10.7M Buy
89,414
+85,127
+1,986% +$10.2M 0.03% 346
2015
Q1
$448K Buy
4,287
+2,223
+108% +$225K ﹤0.01% 1351
2014
Q4
$200K Buy
2,064
+64
+3% +$5.93K ﹤0.01% 1359
2014
Q3
$156K Sell
2,000
-134
-6% -$8.64K ﹤0.01% 1980
2014
Q2
$135K Buy
2,134
+1,134
+113% +$67.4K ﹤0.01% 1921
2014
Q1
$49.5K Buy
1,000
+246
+33% +$19K ﹤0.01% 2131
2013
Q4
$48.5K Sell
754
-15,205
-95% -$907K ﹤0.01% 1932
2013
Q3
$1.02M Sell
15,959
-4,443
-22% -$221K ﹤0.01% 1127
2013
Q2
$633K Buy
+20,402
New +$543K ﹤0.01% 1337

Other funds holding ALNY